Latest filing published 13 Jan 2020 for Infinity Pharmaceuticals, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Lawrence E. Bloch discloses dealings in Infinity Pharmaceuticals, Inc. to SEC (Form 4). Between 31 October 2016 and 10 January 2020, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 1 purchase worth €765k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants.
The record was last updated on 13 January 2020 with a share grant in Infinity Pharmaceuticals, Inc. The last purchase on record was published on 7 December 2017, which is 3,242 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations